Healthcare services company Agilon Health (NYSE: AGL) will be announcing earnings results tomorrow after the bell. Here’s what to look for.
agilon health met analysts’ revenue expectations last quarter, reporting revenues of $1.52 billion, up 44.2% year on year. It was a softer quarter for the company, with full-year EBITDA guidance missing analysts’ expectations and a significant miss of analysts’ EPS estimates. It added 2,000 customers to reach a total of 527,000.
Is agilon health a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting agilon health’s revenue to decline 6.2% year on year to $1.51 billion, a reversal from the 52.2% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.01 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. agilon health has missed Wall Street’s revenue estimates six times over the last two years.
Looking at agilon health’s peers in the healthcare providers & services segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Encompass Health delivered year-on-year revenue growth of 10.6%, beating analysts’ expectations by 1.7%, and Select Medical reported revenues up 2.4%, falling short of estimates by 2.6%. Encompass Health traded up 11.8% following the results while Select Medical was down 21.8%.
Read our full analysis of Encompass Health’s results here and Select Medical’s results here.
There has been positive sentiment among investors in the healthcare providers & services segment, with share prices up 4.3% on average over the last month. agilon health is down 2.4% during the same time and is heading into earnings with an average analyst price target of $4.32 (compared to the current share price of $4.15).
Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
